The Boston group, better at getting and spending a much larger grant, have provided a clear answer: Acupuncture is of no value for the treatment of hypertension. The validity of their data seems certain. Despite the usual litany of limitations at the end of the Discussion section, this trial comes as close as humanly possible to test the effects of repeated acupuncture.
The authors clearly recognized the pitfalls of such a trial and avoided them. To enroll and keep the large number of subjects in the trial is a tribute to the tenacity and organizing skill of the investigators. Likely, the Boston Red Sox looked to them for motivation to win (their only) World Series.
The consequences of this study should be profound. It has proved that, in the authors' words: "Twice-weekly acupuncture is unlikely to be cost-effective relative to available pharmacological treatments for hypertension, nor is it likely to be widely embraced by patients solely on the basis of any mild antihypertensive effect given the significant time required for acupuncture therapy."
Unfortunately, the nature of hypertension and the attractions of acupuncture will probably overcome the hope that it will not continue "to be widely embraced by patients." Scientific medicine is doing a poor job of controlling the "silent killer," and many patients are more than willing to grasp at straws and to embrace long needles stuck in strange places.
The money and effort expended in this trial should save even more wasted money and ineffectual effort. Acupuncture is receiving a number of proofs of inadequacy, [3] [4] [5] but it may turn out that science cannot trump 2500 years of Asian tradition.
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